Breast scaffold safety tracked for years after implant revision
NCT ID NCT07383012
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 19 women who previously received a PCL breast scaffold combined with their own fat during breast implant revision surgery. Researchers will check for device-related side effects and whether mammograms still work well with the scaffold. Participants will have annual visits for up to 5 years after their original surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PCL breast scaffold combined with autologous fat grafting
What this could lead to
If successful, this could show that PCL scaffolds are a safe, long-term option for breast reconstruction after implant revision, and that mammography remains reliable for screening.
What could go wrong
This is a small, long-term follow-up study with only 19 participants, so results may not apply to everyone. It is observational and does not test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST IMPLANT REVISION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Brisbane and Women's Hospital (RBWH), Herston Biofabrication Institute (HBI)
Brisbane, Queensland, Australia, 4029, Australia
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact